Quarterly report pursuant to Section 13 or 15(d)

Net Earnings (Loss) per Share - Summary Of Potentially Dilutive Securities Excluded From Computation of Diluted Net Loss Per Share (Details)

v3.22.2.2
Net Earnings (Loss) per Share - Summary Of Potentially Dilutive Securities Excluded From Computation of Diluted Net Loss Per Share (Details) - shares
6 Months Ended
Jul. 03, 2022
Jun. 30, 2021
Subsidiary Sale Of Stock [Line Items]    
Anti-dilutive securities (in shares)   0
Stock options    
Subsidiary Sale Of Stock [Line Items]    
Anti-dilutive securities (in shares) 5,359,658 5,547,490
Restricted stock units and performance restricted stock units outstanding    
Subsidiary Sale Of Stock [Line Items]    
Anti-dilutive securities (in shares) 5,902,643 0
Private Placement Warrants    
Subsidiary Sale Of Stock [Line Items]    
Anti-dilutive securities (in shares) 6,000,000  
Employee stock purchase plan estimated shares    
Subsidiary Sale Of Stock [Line Items]    
Anti-dilutive securities (in shares) 380,847 0